A Retrospective Analysis of Uterine Leiomyosarcoma in Premenopausal Women in Terms of Gene Expression, ER and PR Expression,ER and PR Expression, Treatment and Overall Survival: Experience of 8 Years from a Canadian Province.

A Retrospective Analysis of Uterine Leiomyosarcoma in Premenopausal Women in Terms of Gene Expression, ER and PR Expression,ER and PR Expression, Treatment and Overall Survival: Experience of 8 Years from a Canadian Province.

^*Corresponding Author:

Copyright: © 2020 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF

Abstract

ABSTRACT:Uterine leiomyosarcoma is a highly lethal malignancy. It affects approximately 0.4/100 000 women each year. The aim of this study is to assess p16 and p53 gene expression, Estrogen & progesterone receptor positivity, treatment, and prognosis of women diagnosed with uterine leiomyosarcoma. The median patient age was 45 years (range, 28-54 years). The pre-operative diagnosis of sarcoma was suspected in 15/39 patients only. Total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed for all patients, with additional surgical procedures (e.g., tumor resection, lymphadenectomy) performed if necessary

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access